CDK 4/6 Inhibitors in Metastatic Breast Cancer

1 Visualizzazioni
administrator
administrator
07/03/23

Hope S. Rugo, MD, discusses the use of CDK 4/6 inhibitors and their impact on the treatment paradigm for metastatic breast cancer.

  • Categoria

Mostra di piรน

0 Commenti Ordina per

Nessun commento trovato

Commenti su Facebook

Avanti il prossimo